Article: Sandy, Toxic Mold, and (at last) a theory potentially explaining 'Sick Building Syndrome'

4. World Health Organization Indoor Air Quality: Biological Contaminants, 4-9, Report on a WHO Meeting, Rautavaara, 29 August-2 September 1988

5.   Chen JW, Luo YL, Hwang MJ, Peng FC, Ling KH. Territrem B, a tremorgenic mycotoxin that inhibits acetylcholinesterase with a noncovalent yet irreversible binding mechanism. 1999 J Biol Chem Dec 3; 274(49):34916-23

6.   Shiomi K, Tomoda H, Otoguro K, Omura S. Meroterpenoids with various biological activities produced by fungi. 1999 Pure Appl. Chem., Vol. 71, No. 6, pp. 1059-1064

7.   Schwab CJ, Straus DC. The roles of Penicillium and Aspergillus in sick
building syndrome. Adv Appl Microbiol 2004; 55:215-38

8.   Edvardsson B, Stenberg B, Bergdahl J, Eriksson N, Linden G, Widman L. Medical and social prognosis of non-specific building-related symptoms (Sick Building Syndrome): a follow-up study of patients previously referred to hospital. Int Arch Occup Environ Health 2008 Jul; 81(7):805-12

9. Gorny RL, Reponen T, Willeke K, Schmechel D, Robine E, Boissier M,
Grinshpun S. Fungal Fragments as Indoor Air Biocontaminants. Appl Environ Microbiol. 2002 July; 68(7): 3522-3531

10. Bloom E, Bal K, Nyman E, Must A, Larsson L. Mass Spectrometry-Based Strategy for Direct Detection and Quantification of Some Mycotoxins Produced by Stachybotrys and Aspergillus spp. in Indoor Environments. Appl Environ Microbiol. 2007 July; p. 4211-4217, Vol. 73, No. 13

11. Haley RW, Billecke S, La Du BN. Association of Low PON1 Type Q
   (Type A) Arylesterase Activity with Neurologic Symptom Complexes in Gulf War Veterans. Toxicol Appl Pharmacol 1999 Jun 15;157(3):227-33.

12. McKeown-Eyssen G, Baines C, Cole DEC, Riley N, Tyndale RF, Marshall L, Jazmaji V. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR. Int J Epidemiol 2004 Oct;33(5):971-8.

13.   Rainwater DL, Mahaney MC, Wang XL, Rogers J, Cox LA, Vandeberg JL Determinants of variation in serum paraoxonase enzyme activity in baboons. 2005 Jul;46(7):1450-6. Epub 2005 Apr 16.

14.   Gouedard C, Koum-Besson N, Barouki R, Morel Y. Opposite regulation of the human paraoxonase-1 gene PON-1 by fenofibrate and statins. Mol Pharmacol, 2003 Apr;63(4):945-56.

Next Page 1 | 2 | 3 | 4 | 5

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).